BCAL Diagnostics Limited (AU:BDX) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
BCAL Diagnostics Limited’s Director, Jayne Shaw, has increased her stake in the company by acquiring 2,000,000 ordinary shares and 2,000,000 options, reflecting a strategic move approved at the recent Annual General Meeting. This acquisition, which involves no cash consideration, could indicate confidence in the company’s future prospects. Investors may want to watch how this development impacts BCAL Diagnostics’ performance in the stock market.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.